ABSTRACT
Aims: Peripheral neuropathy (PN) is correlated with obesity and metabolic syndrome. Intermittent fasting (IF) has been described as the cornerstone in the management of obesity; however, its role in prediabetic complications is not well elucidated. Cytochromes P450 Monooxygenases (CYP450) are major sources of Reactive Oxygen Species (ROS) that orchestrate the onset and development of diabetic complications. One of the CYP-metabolites, Expoxyecosatetraenoic Acids (EETs), are considered to be negative regulators of ROS production. In this study, we elucidated the role of IF on ROS production and investigated its influence on prediabetes-induced PN. Methods: C57/BL6 control mice, prediabetic, prediabetic that underwent alternate day fasting with different diet composition, and prediabetic mice treated with EET-metabolizing sEH-inhibitor, AUDA. Body mass composition, metabolic, behavioral, and molecular tests were performed. Results: High-fat diet (HFD) led to an increase in NADPH-induced ROS production; that was due to an alteration in the epoxygenase pathway assessed by the decrease in CYP1a1/1a2 expression. IF reinstated the homeostatic levels of EETs in HFD-fed mice. Moreover, treatment with AUDA mimicked the beneficial effect observed with IF. Conclusion: IF and EETs bioavailability have a protective role in prediabetes-induced PN, suggesting a novel interventional strategy in the management of prediabetes and its associated complications.
ABSTRACT
Diabetic Peripheral Neuropathy (DPN), highly prevalent among patients with diabetes, is characterized by peripheral nerve dysfunction. Reactive Oxygen Species (ROS) overproduction has been suggested to orchestrate diabetic complications including DPN. Untargeted antioxidant therapy has exhibited limited efficacy, highlighting a critical need to explore ROS sources altered in a cell-specific manner in DPN. Cytochromes P450 (CYP) enzymes are prominent sources of ROS. Particularly, the 20-HETE synthase, CYP4A, is reported to mediate diabetes-induced renal, retinal, and cardiovascular injuries. This work investigates the role of CYP4A/20-HETE in DPN and their mechanisms of action. Non-obese type 2 Diabetic mice (MKR) were used and treated with a CYP4A-inhibitor (HET0016) or AMPK-activator (Metformin). Peripheral nerves of MKR mice reflect increased CYP4A and 20-HETE levels, concurrent with altered myelin proteins and sensorimotor deficits. This was associated with increased ROS production and altered Beclin-1 and LC3 protein levels, indicative of disrupted autophagic responses in tandem with AMPK inactivation. AMPK activation via Metformin restored nerve integrity, reduced ROS production, and regulated autophagy. Interestingly, similar outcomes were revealed upon HET0016 treatment whereby ROS production, autophagic responses, and AMPK signaling were normalized in diabetic mice. Altogether, the results highlight hyperglycemia-mediated oxidative injury in DPN through a novel CYP4A/20-HETE/AMPK pathological axis. PERSPECTIVE: To our knowledge, this is the first study to highlight the role of CYPs/20-HETE-induced oxidative injury in the pathogenesis of diabetic peripheral neuropathy. Targeting the identified pathological axis CYP4A/20-HETE/AMPK may be of clinical potential in predicting and alleviating peripheral nerve injury in patients with Type 2 Diabetes Mellitus.
Subject(s)
Cytochrome P-450 CYP4A , Diabetes Mellitus, Experimental , Diabetes Mellitus, Type 2 , Diabetic Neuropathies , Peripheral Nerve Injuries , Animals , Mice , AMP-Activated Protein Kinases/metabolism , Cytochrome P-450 CYP4A/metabolism , Diabetes Mellitus, Experimental/complications , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Type 2/complications , Diabetic Neuropathies/complications , Hydroxyeicosatetraenoic Acids , Metformin/pharmacology , Oxidative Stress , Peripheral Nerve Injuries/complications , Peripheral Nerves , Reactive Oxygen Species/metabolismABSTRACT
Inflammatory breast cancer is a highly aggressive form of breast cancer that forms clusters of tumor emboli in dermal lymphatics and readily metastasizes. These cancers express high levels of E-cadherin, the major mediator of adherens junctions, which enhances formation of tumor emboli. Previous studies suggest that E-cadherin promotes cancer when the balance between apical and basolateral cadherin complexes is disrupted. Here, we used immunohistochemistry of inflammatory breast cancer patient samples and analysis of cell lines to determine the expression of PLEKHA7, an apical adherens junction protein. We used viral transduction to re-express PLEKHA7 in inflammatory breast cancer cells and examined their aggressiveness in 2D and 3D cultures and in vivo. We determined that PLEKHA7 was deregulated in inflammatory breast cancer, demonstrating improper localization or lost expression in most patient samples and very low expression in cell lines. Re-expressing PLEKHA7 suppressed proliferation, anchorage independent growth, spheroid viability, and tumor growth in vivo. The data indicate that PLEKHA7 is frequently deregulated and acts to suppress inflammatory breast cancer. The data also promote the need for future inquiry into the imbalance between apical and basolateral cadherin complexes as driving forces in inflammatory breast cancer.
Subject(s)
Adherens Junctions/metabolism , Antigens, CD/genetics , Cadherins/genetics , Carrier Proteins/genetics , Catenins/genetics , Inflammatory Breast Neoplasms/genetics , Adherens Junctions/drug effects , Adherens Junctions/pathology , Animals , Antibiotics, Antineoplastic/pharmacology , Antigens, CD/metabolism , Caco-2 Cells , Cadherins/metabolism , Carrier Proteins/metabolism , Catenins/metabolism , Cell Line, Tumor , Cell Proliferation/drug effects , Doxorubicin/analogs & derivatives , Doxorubicin/pharmacology , Female , Gene Expression Regulation, Neoplastic , Humans , Inflammatory Breast Neoplasms/drug therapy , Inflammatory Breast Neoplasms/metabolism , Inflammatory Breast Neoplasms/pathology , Lymphatic Metastasis , Mice , Mice, SCID , Polyethylene Glycols/pharmacology , Signal Transduction , Spheroids, Cellular/drug effects , Spheroids, Cellular/metabolism , Spheroids, Cellular/pathology , Tumor Burden/drug effects , Xenograft Model Antitumor Assays , Delta CateninABSTRACT
Diabetes triggers peripheral nerve alterations at a structural and functional level, collectively referred to as diabetic peripheral neuropathy (DPN). This work highlights the role of the liver X receptor (LXR) signaling pathway and the cross talk with the reactive oxygen species (ROS)-producing enzyme NADPH oxidase-4 (Nox4) in the pathogenesis of DPN. Using type 1 diabetic (T1DM) mouse models together with cultured Schwann cells (SCs) and skin biopsies from patients with type 2 diabetes (T2DM), we revealed the implication of LXR and Nox4 in the pathophysiology of DPN. T1DM animals exhibit neurophysiological defects and sensorimotor abnormalities paralleled by defective peripheral myelin gene expression. These alterations were concomitant with a significant reduction in LXR expression and increase in Nox4 expression and activity in SCs and peripheral nerves, which were further verified in skin biopsies of patients with T2DM. Moreover, targeted activation of LXR or specific inhibition of Nox4 in vivo and in vitro to attenuate diabetes-induced ROS production in SCs and peripheral nerves reverses functional alteration of the peripheral nerves and restores the homeostatic profiles of MPZ and PMP22. Taken together, our findings are the first to identify novel, key mediators in the pathogenesis of DPN and suggest that targeting LXR/Nox4 axis is a promising therapeutic approach.
Subject(s)
Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Type 1/metabolism , Diabetes Mellitus, Type 2/metabolism , Diabetic Neuropathies/metabolism , Liver X Receptors/metabolism , NADPH Oxidase 4/metabolism , Schwann Cells/metabolism , Aged , Aged, 80 and over , Animals , Diabetes Mellitus, Experimental/complications , Diabetes Mellitus, Type 1/complications , Diabetes Mellitus, Type 2/complications , Diabetic Neuropathies/etiology , Female , Humans , Hydrocarbons, Fluorinated/pharmacology , Liver X Receptors/agonists , Male , Mice , Myelin Proteins/genetics , NADPH Oxidase 4/antagonists & inhibitors , Pyrazoles/pharmacology , Pyrazolones , Pyridines/pharmacology , Pyridones , Reactive Oxygen Species/metabolism , Signal Transduction , Sulfonamides/pharmacologyABSTRACT
Cancer was recently annexed to diabetic complications. Furthermore, recent studies suggest that cancer can increase the risk of diabetes. Consequently, diabetes and cancer share many risk factors, but the cellular and molecular pathways correlating diabetes and colon and rectal cancer (CRC) remain far from understood. In this study, we assess the effect of hyperglycemia on cancer cell aggressiveness in human colon epithelial adenocarcinoma cells in vitro and in an experimental animal model of CRC. Our results show that Nox (NADPH oxidase enzyme) 4-induced reactive oxygen species (ROS) production is deregulated in both diabetes and CRC. This is paralleled by inactivation of the AMPK and activation of the mammalian target of rapamycin (mTOR) C1 signaling pathways, resulting in 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG) accumulation, induction of DNA damage, and exacerbation of cancer cell aggressiveness, thus contributing to the genomic instability and predisposition to increased tumorigenesis in the diabetic milieu. Pharmacologic activation of AMPK, inhibition of mTORC1, or blockade of Nox4 reduce ROS production, restore the homeostatic signaling of 8-oxoguanine DNA glycosylase/8-oxodG, and lessen the progression of CRC malignancy in a diabetic milieu. Taken together, our results identify the AMPK/mTORC1/Nox4 signaling axis as a molecular switch correlating diabetes and CRC. Modulating this pathway may be a strategic target of therapeutic potential aimed at reversing or slowing the progression of CRC in patients with or without diabetes.-Mroueh, F. M., Noureldein, M., Zeidan, Y. H., Boutary, S., Irani, S. A. M., Eid, S., Haddad, M., Barakat, R., Harb, F., Costantine, J., Kanj, R., Sauleau, E.-A., Ouhtit, A., Azar, S. T., Eid, A. H., Eid, A. A. Unmasking the interplay between mTOR and Nox4: novel insights into the mechanism connecting diabetes and cancer.
Subject(s)
NADPH Oxidase 4/metabolism , TOR Serine-Threonine Kinases/metabolism , AMP-Activated Protein Kinases/antagonists & inhibitors , Animals , Antibiotics, Antineoplastic/pharmacology , Blood Glucose , Caco-2 Cells , DNA Damage , Diabetes Mellitus, Experimental , Gene Expression Regulation, Neoplastic/drug effects , HT29 Cells , Humans , Hypoglycemic Agents/pharmacology , Male , Metformin/pharmacology , Mice , Mice, Inbred C57BL , Mice, Transgenic , NADPH Oxidase 4/genetics , Sirolimus/pharmacology , TOR Serine-Threonine Kinases/antagonists & inhibitors , TOR Serine-Threonine Kinases/genetics , Up-RegulationABSTRACT
Since the very beginning of his papacy, Pope Francis has provided a field day for the media. With well over 10 million people following him on Twitter, it is no wonder that many of his statements have become quotable quotes. One in particular has garnered much attention: "I see clearly that what the Church needs today is the ability to heal wounds and to warm the hearts of the faithful; it needs nearness, proximity [to the people]. I see the Church as a field hospital after a battle."
Subject(s)
Catholicism , Military Medicine , Mobile Health Units , Humans , TelevisionABSTRACT
As global sea levels and natural resource demands rise, people around the world are increasingly protesting environmental threats to their lives and livelihoods. What are the conditions under which these peaceful environmental protests are violently repressed? This paper uses the random forest algorithm to conduct an event analysis of grassroots environmental protests around the world. Utilizing a database of 175 grassroots environmental protests, we found that: (1) a large proportion (37 %) of the protests involved violent repression; (2) most of the violence (56 %) was directed against marginalized groups; and (3) violence was geographically concentrated the global south in Latin America and Asia. The primary predictors of violence were political empowerment, GDP per capita, industry type, the presence of marginalized groups, and geographic region. Our analysis reveals a complex relationship between governance, resource extraction, and international funding that often resulted in human rights violations against marginalized groups.
ABSTRACT
Leadership is the vital ingredient to achieving organizational excellence and outstanding healthcare systems. There is so much to be celebrated when reflecting on the evolution of healthcare leadership over the past 50 years. However, in 50 years, we have created silos of care, of funding and of social policy that have undermined our progress in improving the care process, shifting away from health and toward healthcare, and we have lost the opportunity to promote streamlined care through the continuum of health needs. Exemplary healthcare leaders of tomorrow will need sophisticated business skills, balanced with the capacity to inspire innovation, in order to manage an ever-growing complex environment.
Subject(s)
Hospital Administration , Leadership , Hospital Administrators , Humans , Quality of Health CareSubject(s)
Child Welfare , Health Policy , Adolescent , Canada , Child , Diffusion of Innovation , HumansSubject(s)
Child Welfare , Health Priorities , Canada , Child , Health Policy , Humans , National Institutes of Health (U.S.) , Quality Improvement , United StatesABSTRACT
This second instalment in our Child Health in Canada series explores a multi-faceted topic that weighs especially heavy on the minds of parents, teachers, care providers, policy makers, social workers and many others: mental health. After all, as Stan Kutcher asserts in his contribution to this issue, "there can be no health without mental health."
Subject(s)
Child Health , Adolescent , Canada , Child , Child Health Services , Humans , Mental HealthSubject(s)
Child Health Services , Child Welfare , Goals , Canada , Child , Humans , National Health ProgramsSubject(s)
Catholicism , Social Justice , Female , Health Care Reform , Humans , Leadership , United StatesSubject(s)
Empathy , Geriatric Nursing , Patient Satisfaction , Professional-Patient Relations , Aged , Humans , Residential FacilitiesABSTRACT
A case of clear cell ovarian cancer and endometriosis in a postmenopausal patient following adjuvant tamoxifen for breast cancer is presented. Immunohistochemistry demonstrated the tumor to be positive for progesterone receptor protein but not estrogen receptor protein; the endometriosis was positive for both proteins. Literature review reveals this to be the first report of both clear cell ovarian cancer and endometriosis following tamoxifen use, and the third report of epithelial ovarian cancer associated with tamoxifen.